Hepatocellular carcinoma not associated with virus B and C and alcohol

Hepatocellular carcinoma not associated with virus B and C and alcohol

Bibliographic Details
Main Authors:	Aldo Dardón, M.D., Roberto Corona, M.D., Nahum Méndez-Sánchez, M.D., PhD
Format:	Article
Language:	English
Published:	Elsevier 2003-01-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119321581

Similar Items

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
by: Peter Lee, BS, et al.
Published: (2020-09-01)

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
by: Paulina Chinchilla-López, et al.
Published: (2017-05-01)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
by: Naoko Kakuta, MD, et al.
Published: (2021-06-01)

The Latin American Association for the Study of the Liver in its Meeting on Diagnosis, Management and Treatment of Hepatitis C
by: Nahum Méndez-Sánchez, MD, PhD
Published: (2010-01-01)

Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Chiao-Fang Teng, et al.
Published: (2017-03-01)

Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma
by: Yusuke Imai, MD, et al.
Published: (2017-03-01)

A case of primary clear cell hepatocellular carcinoma comprised mostly of clear cells
by: Reiji Kokubo, MD, et al.
Published: (2019-11-01)

Cured giant hepatocellular carcinoma after transarterial embolization complicated with liver abscess formation
by: Malkhaz Mizandari, MD,PhD, et al.
Published: (2020-09-01)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
by: Antonio Orlacchio, M.D., et al.
Published: (2020-12-01)

Editor’s Report
by: Nahum Méndez-Sánchez, M.D., PhD
Published: (2003-01-01)

Hepatology Highlights
by: Nahum Méndez-Sánchez, M.D., Ph.D.
Published: (2003-01-01)

From the editor
by: Nahum Méndez-Sánchez, M.D. PhD
Published: (2009-01-01)

Hepatology Highlights
by: Nahum Méndez-Sánchez, M.D., Ph.D.
Published: (2011-07-01)

Hepatology Highlights
by: Méndez-Sánchez Nahum, M.D., PhD
Published: (2012-03-01)

Instructions to Authors
by: Nahum Méndez-Sánchez, M.D.,PhD
Published: (2013-09-01)

Annals of Hepatology. What is next?
by: Nahum. Méndez-Sánchez, M.D., Ph.D.
Published: (2010-01-01)

Hepatology Highlights
by: Nahum Méndez-Sánchez, M.D. PhD
Published: (2009-07-01)

Hepatology Highlights
by: Nahum Méndez-Sánchez, M.D. PhD
Published: (2009-01-01)

Caroli's Disease and Choledochal Cyst
by: Jorge Hérnandez-Ortiz, MD, et al.
Published: (2002-10-01)

The good, the bad and the ugly of the new treatments for hepatitis C virus
by: Karen V. Silva-Vidal, et al.
Published: (2014-09-01)

SALLuting a new biomarker in hepatocellular carcinoma
by: Andrea L. Inghilesi, et al.
Published: (2014-03-01)

The Quest for Relevant Hepatocellular Carcinoma Biomarkers
by: Jin U. Kim BSc,, MD, et al.
Published: (2017-09-01)

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
by: Silvia Pietrobono, MD, et al.
Published: (2021-01-01)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
by: Birke Bartosch
Published: (2010-07-01)

Skin ischemia and ulceration as a complication of inferior phrenic artery embolization for hepatocellular carcinoma
by: Sukjin Koh, MD, et al.
Published: (2018-06-01)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
by: Liping Zhuang MD, PhD, et al.
Published: (2020-11-01)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
by: Xinlun Dai MD, et al.
Published: (2020-08-01)

Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities
by: Jens Hemmingsson, MS, et al.
Published: (2018-07-01)

Annals of Hepatology. Comment from the Editor
by: Nahum Méndez-Sánchez, MD, PhD
Published: (2005-01-01)

Annals of hepatology: A new medical journal
by: Nahum Méndez-Sánchez, MD, PhD
Published: (2002-01-01)

Annals of Hepatology. Second Year go on
by: Nahum Méndez-Sánchez, MD, PhD
Published: (2004-01-01)

A comment from the Editor
by: Méndez-Sánchez Nahum, MD, PhD
Published: (2011-10-01)

High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC
by: Tingting Shen MD, et al.
Published: (2020-03-01)

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
by: Ronik S. Bhangoo, MD, et al.
Published: (2021-07-01)

Methicillin-Resistant Subspecies Infection in a Patient With Hepatocellular Carcinoma
by: Thein Swe MD, et al.
Published: (2016-09-01)

Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
by: Hao Zheng, et al.
Published: (2017-01-01)

Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the Gene
by: Yajing Huang MD, et al.
Published: (2020-02-01)

Analysis of Extrahepatic Collateral Arteries in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
by: Chanon Ngamsombat, M.D., et al.
Published: (2018-05-01)

Hepatology Highlights
by: Eric M. Yoshida, M.D., et al.
Published: (2009-10-01)

Surveillance for hepatocellular carcinoma: in whom and how?
by: Hashem B. El-Serag MD, MPH, et al.
Published: (2011-01-01)